Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about XNAS:GOVX

Recent news which mentions XNAS:GOVX

< Previous 1 2 Next >
GeoVax to Participate in BIO International Convention 2025
Tickers GOVX
Tags en/US XNAS:GOVX GeoVax, Inc/
From TheNewswire.com - RSS (Media)
GeoVax Responds to WHO's Fourth Declaration of Mpox as a Global Public Health Emergency
Tickers GOVX
Tags GeoVax, Inc/ XNAS:GOVX en/US
From TheNewswire.com - RSS (Media)
GeoVax Announces Upcoming Presentation at the European Hematology Association 2025 Congress Highlighting Positive Immune Response Data for GEO-CM04S1 in CLL Patients
Tickers GOVX
Tags en/US XNAS:GOVX GeoVax, Inc/
From TheNewswire.com - RSS (Media)
GeoVax Highlights Broad Cross-Protective Immunity of Multi-Antigen COVID-19 Vaccine Candidates at Keystone Symposia
Tickers GOVX
Tags GeoVax, Inc/ XNAS:GOVX en/US
From TheNewswire.com - RSS (Media)
GeoVax to Showcase Innovative COVID 19 Vaccine Data at the Keystone Symposia on Vaccinology
Tickers GOVX
Tags en/US XNAS:GOVX GeoVax, Inc/
From TheNewswire.com - RSS (Media)
GeoVax Congratulates Bipartisan Senate Action to Onshore Critical Medical Manufacturing
Tickers GOVX
Tags en/US GeoVax, Inc/ XNAS:GOVX
From TheNewswire.com - RSS (Media)
GeoVax Commends FDA's Shift to Risk-Based COVID-19 Vaccination Guidance
Tickers GOVX
Tags XNAS:GOVX GeoVax, Inc/ en/US
From TheNewswire.com - RSS (Media)
GeoVax Applauds EQUIP-A-Pharma Initiative, Reinforces Commitment to Domestic Vaccine Manufacturing and Biodefense Innovation
Tickers GOVX
Tags GeoVax, Inc/ XNAS:GOVX en/US
From TheNewswire.com - RSS (Media)
GeoVax Reaffirms Urgent Need for Multi-Antigen COVID-19 Vaccines as CDC Shifts Recommendations
Tickers GOVX
Tags en/US GeoVax, Inc/ XNAS:GOVX
From TheNewswire.com - RSS (Media)
GeoVax Highlights Dual Protective Potential of GEO-CM04S1 Following Presentation at the AAI Annual Meeting 2025
Tickers GOVX
Tags GeoVax, Inc/ XNAS:GOVX en/US
From TheNewswire.com - RSS (Media)
GeoVax Expands Gedeptin(R) Patent Portfolio
Tickers GOVX R
Tags GeoVax, Inc/ XNAS:GOVX en/US
From TheNewswire.com - RSS (Media)
GeoVax Applauds White House Executive Order Supporting U.S. Pharmaceutical Manufacturing; Highlights Progress in Domestic MVA Vaccine Production
Tickers GOVX
Tags en/US GeoVax, Inc/ XNAS:GOVX
From TheNewswire.com - RSS (Media)
GeoVax Reports First Quarter 2025 Financial Results and Provides Business Update
Tickers GOVX
Tags en/US XNAS:GOVX GeoVax, Inc/
From TheNewswire.com - RSS (Media)
GeoVax Presents Gedeptin(R) Clinical Data at the American Association for Cancer Research Annual Meeting
Tickers GOVX R
Tags en/US XNAS:GOVX GeoVax, Inc/
From TheNewswire.com - RSS (Media)
GeoVax Responds to Detection of Clade I Mpox in North Carolina Wastewater
Tickers GOVX
Tags XNAS:GOVX GeoVax, Inc/ en/US
From TheNewswire.com - RSS (Media)
GeoVax Highlights Strong Clinical Results Following Presentation of Multi-Antigen COVID-19 Vaccine at the 25th Annual World Vaccine Congress
Tickers GOVX
Tags GeoVax, Inc/ XNAS:GOVX en/US
From TheNewswire.com - RSS (Media)
GeoVax to Report First Quarter 2025 Financial Results and Provide Corporate Update on May 1, 2025
Tickers GOVX
Tags GeoVax, Inc/ XNAS:GOVX en/US
From TheNewswire.com - RSS (Media)
GeoVax Appoints Dr. Senthil Ranganathan as Vice President, Technical Development and CMC Operations
Tickers GOVX
Tags GeoVax, Inc/ XNAS:GOVX en/US
From TheNewswire.com - RSS (Media)
GeoVax Highlights New Study Demonstrating the Strength of Multi-Antigen COVID-19 Vaccine Candidates
Tickers GOVX
Tags XNAS:GOVX GeoVax, Inc/ en/US
From TheNewswire.com - RSS (Media)
GeoVax Provides Update on BARDA Project NextGen and Outlines 2025 Business Momentum
Tickers GOVX
Tags en/US XNAS:GOVX GeoVax, Inc/
From TheNewswire.com - RSS (Media)
GeoVax to Present at the Emerging Growth Conference on April 16, 2025
Tickers GOVX
Tags en/US GeoVax, Inc/ XNAS:GOVX
From TheNewswire.com - RSS (Media)
GeoVax to Present Clinical Data at Upcoming April Industry Events
Tickers GOVX
Tags GeoVax, Inc/ XNAS:GOVX en/US
From TheNewswire.com - RSS (Media)
GeoVax Receives USPTO Notice of Allowance for Marburg Hemorrhagic Fever Vaccine Patent
Tickers GOVX
Tags XNAS:GOVX GeoVax, Inc/ en/US
From TheNewswire.com - RSS (Media)
GeoVax Reports 2024 Year-End Financial Results and Provides Business Update
Tickers GOVX
Tags en/US GeoVax, Inc/ XNAS:GOVX
From TheNewswire.com - RSS (Media)
GeoVax Labs Announces $4.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Tickers GOVX
Tags en/US GeoVax, Inc/ XNAS:GOVX
From TheNewswire.com - RSS (Media)
GeoVax to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Corporate Update on March 27, 2025
Tickers GOVX
Tags en/US XNAS:GOVX GeoVax, Inc/
From TheNewswire.com - RSS (Media)
GeoVax Establishing Strategic Presence in Europe With Initial Footprint in the UK
Tickers GOVX
Tags GeoVax, Inc/ XNAS:GOVX en/US
From TheNewswire.com - RSS (Media)
GeoVax to Present at the 37th Annual Roth Conference
Tickers GOVX
Tags en/US XNAS:GOVX GeoVax, Inc/
From TheNewswire.com - RSS (Media)
Registration is Now Open For Tribe Public's CEO Presentation and Q&amp;A Webinar Event MPOX 2025: Navigating the Global Public Health Emergency Featuring GeoVax CEO On March 6, 2025
Tickers GOVX
Tags XNAS:GOVX GeoVax, Inc/ en/US
From TheNewswire.com - RSS (Media)
GeoVax Highlights the Critical Role of MVA-Based Vaccines in U.S. Biodefense Strategy
Tickers GOVX
Tags XNAS:GOVX GeoVax, Inc/ en/US
From TheNewswire.com - RSS (Media)
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.